-
If you purchased shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX), you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
August 18, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) shares over potential securities laws violations by Nymox Pharmaceutical Corporation (NASDAQ:NYMX and certain of its directors and officers in connection certain financial statements was announced.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) concerning whether a series of statements by Nymox Pharmaceutical Corporation (NASDAQ:NYMX regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On August 10, 2016, an article was published alleging that Nymox Pharmaceutical Corporation management has consistently and repeatedly misled shareholders about its prospects in a material way while dumping stock at inflated prices without making timely disclosures to the Securities and Exchange Commission.
Shares o Nymox Pharmaceutical Corporation (NASDAQ:NYMX) declined from $4.02 per share on July 25, 2016 to as low as $1.62 per share on August 10, 2016.
